The modular architecture of meningococcal factor H-binding protein.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Microbiology

• Publication date

  2009-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1099/mic.0.029876-0PMID 19574307PMCID PMC2859308
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidis.

  2009cited by this paper
• Neisseria meningitidis recruits factor H using protein mimicry of host carbohydrates

  2009influential reference
• Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus.

  2009cited by this paper
• Ex Vivo Model of Meningococcal Bacteremia Using Human Blood for Measuring Vaccine-Induced Serum Passive Protective Activity

  2009cited by this paper
• Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease.

  2009cited by this paper
• A region of the N-terminal domain of meningococcal factor H-binding protein that elicits bactericidal antibody across antigenic variant groups.

  2009influential reference
• Meningococcal factor H-binding protein variants expressed by epidemic capsular group A, W-135, and X strains from Africa.

  2009influential reference
• Relative Contributions of Recombination and Mutation to the Diversification of the opa Gene Repertoire of Neisseria gonorrhoeae

  2008cited by this paper
• Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen.

  2008influential reference
• Rapid Detection of the Mosaic Structure of the Neisseria gonorrhoeae penA Gene, Which Is Associated with Decreased Susceptibilities to Oral Cephalosporins

  2008cited by this paper
• The Effect of Immune Selection on the Structure of the Meningococcal Opa Protein Repertoire

  2008cited by this paper
• Bactericidal Antibody Responses Induced by Meningococcal Recombinant Chimeric Factor H-Binding Protein Vaccines

  2008cited by this paper
• Domain annotation of trimeric autotransporter adhesins—daTAA

  2008cited by this paper
• Binding of Complement Factor H (fH) to Neisseria meningitidis Is Specific for Human fH and Inhibits Complement Activation by Rat and Rabbit Sera

  2008cited by this paper
• Fine Antigenic Specificity and Cooperative Bactericidal Activity of Monoclonal Antibodies Directed at the Meningococcal Vaccine Candidate Factor H-Binding Protein

  2008influential reference
• MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0.

  2007influential reference
• Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine.

  2007influential reference
• Clustal W and Clustal X version 2.0

  2007influential reference
• Functional Significance of Factor H Binding to Neisseria meningitidis1

  2006influential reference
• The Meningococcal Vaccine Candidate GNA1870 Binds the Complement Regulatory Protein Factor H and Enhances Serum Resistance

  2006influential reference
• Comparative genomics of Neisseria meningitidis: core genome, islands of horizontal transfer and pathogen-specific genes.

  2006cited by this paper
• Meningococcal Genetic Variation Mechanisms Viewed through Comparative Analysis of Serogroup C Strain FAM18

  2006cited by this paper
• The Region Comprising Amino Acids 100 to 255 of Neisseria meningitidis Lipoprotein GNA 1870 Elicits Bactericidal Antibodies

  2005cited by this paper
• MUSCLE: multiple sequence alignment with high accuracy and high throughput.

  2004cited by this paper
• Protective Activity of Monoclonal Antibodies to Genome-Derived Neisserial Antigen 1870, a Neisseria meningitidis Candidate Vaccine1

  2004cited by this paper
• Vaccine Potential of the Neisseria meningitidis 2086 Lipoprotein

  2004influential reference
• Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870

  2003influential reference
• A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood.

  2003cited by this paper
• Dynamics of the penA gene in serogroup C meningococcal strains.

  2003cited by this paper
• Selection of conserved blocks from multiple alignments for their use in phylogenetic analysis.

  2000cited by this paper
• Variable sequences in a mosaic-like domain of meningococcal tbp2 encode immunoreactive epitopes.

  1995cited by this paper
• * Joint first authors.

  year unknowncited by this paper

• Structural characterization of a cross-protective natural chimera of factor H binding protein from meningococcal serogroup B strain NL096

  2022cites this paper
• Two human antibodies to a meningococcal serogroup B vaccine antigen enhance binding of complement Factor H by stabilizing the Factor H binding site

  2021cites this paper
• Strategies to Designing Chimeric Recombinant Vaccines

  2021cites this paper
• Meningococcal factor H-binding protein as immune evasion factor and vaccine antigen.

  2020cites this paper
• LYME DISEASE AND RELAPSING FEVER SPIROCHETES

  2020cites this paper
• Human and Veterinary Vaccines for Lyme Disease.

  2020cites this paper
• Horizontal Gene Transfer Among Neisseria Species and Humans

  2019cites this paper
• Vaccine antigen, Factor H binding protein, is typically a non-lipidated precursor that localises to the meningococcal surface by Slam

  2019cites this paper
• Horizontal Gene Transfer: Breaking Borders Between Living Kingdoms

  2019cites this paper
• Variant Signal Peptides of Vaccine Antigen, FHbp, Impair Processing Affecting Surface Localization and Antibody-Mediated Killing in Most Meningococcal Isolates

  2019cites this paper
• Potential large scale production of meningococcal vaccines by stable overexpression of fHbp in the rice seeds.

  2018cites this paper
• Clustered intergenic region sequences as predictors of factor H Binding Protein expression patterns and for assessing Neisseria meningitidis strain coverage by meningococcal vaccines

  2018cites this paper
• Molecular characterization of two sub-family specific monoclonal antibodies to meningococcal Factor H binding protein

  2018cites this paper
• Increase of Neisseria meningitidis W:cc11 invasive disease in Chile has no correlation with carriage in adolescents

  2018cites this paper
• 38 – Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines

  2018cites this paper
• Identification and characterization of a novel single‐chain variable fragment (scFv) antibody against Neisseria meningitidis factor H‐binding protein (fHbp)

  2018cites this paper
• The role of apolipoprotein N‐acyl transferase, Lnt, in the lipidation of factor H binding protein of Neisseria meningitidis strain MC58 and its potential as a drug target

  2017cites this paper
• Recent Progress in the Prevention of Serogroup B Meningococcal Disease

  2017cites this paper
• Development of a modular and multiplexed assay to predict the coverage of Bexsero TM against Neisseria meningitidis type B PhD student :

  2017cites this paper
• Meningococcal Factor H Binding Protein Vaccine Antigens with Increased Thermal Stability and Decreased Binding of Human Factor H

  2016cites this paper
• Tipagem molecular de Neisseria meningitidis e investigação da doença meningocócica no Amazonas, 2000 A 2010

  2016cites this paper
• Over-expression of fHbp in Arabdopsis for development of meningococcal serogroup B subunit vaccine.

  2016cites this paper
• Enhanced protective antibody to a mutant meningococcal factor H-binding protein with low-factor H binding.

  2016cites this paper
• A meningococcal vaccine antigen engineered to increase thermal stability and stabilize protective epitopes

  2015cites this paper
• Bivalent rLP2086 Vaccine (Trumenba®): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10–25 Years

  2015cites this paper
• Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other Purposes

  2015cites this paper
• Susceptibility to Invasive Meningococcal Disease: Polymorphism of Complement System Genes and Neisseria meningitidis Factor H Binding Protein

  2015cites this paper
• Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen

  2015cites this paper
• The Discovery and Development of a Novel Vaccine to Protect against Neisseria meningitidis Serogroup B Disease

  2015cites this paper
• Identification of the immunoproteome of the meningococcus by cell surface immunoprecipitation and MS.

  2014cites this paper
• Improving Safety and Efficacy of Meningococcal Vaccines: Vaccines based on a relatively sparse surface lipoprotein extend coverage to serogroup B; amino acid changes could lead to further enhancements

  2014cites this paper
• Surveillance of invasive Neisseria meningitidis with a serogroup Y update, Sweden 2010 to 2012.

  2014cites this paper
• Improving Safety and Efficacy of Meningococcal Vaccines

  2014cites this paper
• Mapping genetic variants in the CFH gene for association with leprosy in Han Chinese

  2014cites this paper
• A broadly-protective vaccine against meningococcal disease in sub-Saharan Africa based on generalized modules for membrane antigens (GMMA).

  2014cites this paper
• Two cross‐reactive monoclonal antibodies recognize overlapping epitopes on Neisseria meningitidis factor H binding protein but have different functional properties

  2014cites this paper
• Advances towards the prevention of meningococcal B disease: a multidimensional story.

  2014cites this paper
• Neisseria meningitidis B vaccines: recent advances and possible immunization policies

  2014cites this paper
• 21 – Meningococcal vaccines

  2013cites this paper
• Role of Factor H Binding Protein in Neisseria meningitidis Virulence and Its Potential as a Vaccine Candidate To Broadly Protect against Meningococcal Disease

  2013cites this paper
• Distinct Binding and Immunogenic Properties of the Gonococcal Homologue of Meningococcal Factor H Binding Protein

  2013cites this paper
• Conservation of Meningococcal Antigens in the Genus Neisseria

  2013cites this paper
• Pathogenesis of meningococcemia.

  2013cites this paper
• Impact of sequence diversity in the Moraxella catarrhalis UspA2/UspA2H head domain on vitronectin binding and antigenic variation.

  2013cites this paper
• A Multi-country Evaluation of Neisseria meningitidis Serogroup B Factor H–Binding Proteins and Implications for Vaccine Coverage in Different Age Groups

  2013cites this paper
• Gene variability and degree of expression of vaccine candidate factor H binding protein in clinical isolates of Neisseria meningitidis

  2013cites this paper
• Use of a Molecular Decoy to Segregate Transport from Antigenicity in the FrpB Iron Transporter from Neisseria meningitidis

  2013cites this paper
• A Broadly Cross-Reactive Monoclonal Antibody Against an Epitope on the N-terminus of Meningococcal fHbp

  2012cites this paper
• Epitope mapping of a mAb against the factor H binding protein (fHbp) of N. meningitidis by phage display

  2012cites this paper
• Bexsero

  2012influential citation
• Potential coverage of an investigational, multi-component, meningococcal vaccine with a focus on the ST-269 clonal complex

  2012cites this paper
• Monoclonal Antibodies to Meningococcal Factor H Binding Protein with Overlapping Epitopes and Discordant Functional Activity

  2012cites this paper
• Meningococcal Factor H Binding Protein fHbpd184 Polymorphism Influences Clinical Course of Meningococcal Meningitis

  2012cites this paper
• Design of Meningococcal Factor H Binding Protein Mutant Vaccines That Do Not Bind Human Complement Factor H

  2012influential citation
• Diversity of factor H-binding protein in Neisseria meningitidis carriage isolates.

  2011cites this paper
• Meningococcal Factor H Binding Proteins in Epidemic Strains from Africa: Implications for Vaccine Development

  2011cites this paper
• Immunogenicity of a meningococcal native outer membrane vesicle vaccine with attenuated endotoxin and over-expressed factor H binding protein in infant rhesus monkeys.

  2011cites this paper
• A Critical Threshold of Meningococcal Factor H Binding Protein Expression Is Required for Increased Breadth of Protective Antibodies Elicited by Native Outer Membrane Vesicle Vaccines

  2011cites this paper
• Effect of Factor H-Binding Protein Sequence Variation on Factor H Binding and Survival of Neisseria meningitidis in Human Blood

  2010cites this paper
• Variation in the Neisseria meningitidis FadL-like protein: an evolutionary model for a relatively low-abundance surface antigen.

  2010cites this paper
• Frequency of factor H-binding protein modular groups and susceptibility to cross-reactive bactericidal activity in invasive meningococcal isolates.

  2010cites this paper
• The temporal and geographical distribution and diversity of disease-associated Neisseria meningitidis genetic types in Europe

  2010cites this paper
• Genetic shifts of Neisseria meningitidis serogroup B antigens and the quest for a broadly cross-protective vaccine

  2010cites this paper
• Characterization of Diverse Subvariants of the Meningococcal Factor H (fH) Binding Protein for Their Ability To Bind fH, To Mediate Serum Resistance, and To Induce Bactericidal Antibodies

  2010cites this paper
• Review of meningococcal group B vaccines.

  2010cites this paper
• The Meningococcal Vaccine Candidate Neisserial Surface Protein A (NspA) Binds to Factor H and Enhances Meningococcal Resistance to Complement

  2010cites this paper
• Vaccine development against Neisseria meningitidis

  2010cites this paper
• Impaired Immunogenicity of a Meningococcal Factor H-Binding Protein Vaccine Engineered To Eliminate Factor H Binding

  2010cites this paper